Cargando…

Erratum to hormonal manipulation in androgen signaling: a narrative review on using novel androgen therapy agents to optimize clinical outcomes and minimize side effects for prostate cancer patients

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575575/ https://www.ncbi.nlm.nih.gov/pubmed/34804851 http://dx.doi.org/10.21037/tau-2021-06

Ejemplares similares

Hormonal manipulation in androgen signaling: a narrative review on using novel androgen therapy agents to optimize clinical outcomes and minimize side effects for prostate cancer patients
por: Lyou, Yung, et al.
Publicado: (2021)

Erratum to “Strategies for Imaging Androgen Receptor Signaling Pathway in Prostate Cancer: Implications for Hormonal Manipulation and Radiation Treatment”
por: Gravina, Giovanni L., et al.
Publicado: (2014)

Erratum to: “The Relationship Between Bone and Reproductive Hormones Beyond Estrogens and Androgens”
Publicado: (2021)

Erratum to: A comparative study of glycoproteomes in androgen-sensitive and -independent prostate cancer cell lines
por: Drabik, Anna, et al.
Publicado: (2014)

Erratum: ETS Related Gene mediated Androgen Receptor Aggregation and Endoplasmic Reticulum Stress in Prostate Cancer Development
por: Sreenath, Taduru L., et al.
Publicado: (2017)

Erratum to: IκBα mediates prostate cancer cell death induced by combinatorial targeting of the androgen receptor
por: Carter, Sarah L., et al.
Publicado: (2016)

Strategies for Imaging Androgen Receptor Signaling Pathway in Prostate Cancer: Implications for Hormonal Manipulation and Radiation Treatment
por: Giovanni Luca, Gravina, et al.
Publicado: (2013)

Hormones and prostate carcinogenesis: Androgens and estrogens
por: Bosland, Maarten C., et al.
Publicado: (2011)

Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
por: Chen, Mengqian, et al.
Publicado: (2010)

Erratum: 3,3′-Diindolylmethane (DIM) and its ring-substituted halogenated analogs (ring-DIMs) induce differential mechanisms of survival and death in androgen-dependent and–independent prostate cancer cells
por: Goldberg, Alexander A., et al.
Publicado: (2016)

Darolutamide: a novel androgen-signaling agent in nonmetastatic castration-resistant prostate cancer
por: Aragon-Ching, Jeanny B
Publicado: (2019)

Erratum to narrative review of management strategies and outcomes in node-positive prostate cancer
Publicado: (2021)

Erratum: Side Effects of Brolucizumab
Publicado: (2022)

Identification of novel genes that regulate androgen receptor signaling and growth of androgen-deprived prostate cancer cells
por: Levina, Elina, et al.
Publicado: (2015)

Steroidogenic enzyme profile in an androgen-secreting adrenocortical oncocytoma associated with hirsustism
por: Nomigni, Milène Tetsi, et al.
Publicado: (2015)

Evolving perspectives of the role of novel agents in androgen-independent prostate cancer
por: Kalmadi, Sujith, et al.
Publicado: (2008)

Erratum: Iridates from the molecular side
por: Pedersen, Kasper S., et al.
Publicado: (2016)

Addition of androgen receptor-targeted agents to androgen-deprivation therapy and docetaxel in metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis
por: Maiorano, B.A., et al.
Publicado: (2022)

Suppressive Role of Androgen/Androgen Receptor Signaling via Chemokines on Prostate Cancer Cells
por: Izumi, Kouji, et al.
Publicado: (2019)

Erratum to design and optimization of auditory prostheses using the finite element method: a narrative review
Publicado: (2022)

P-Glycoprotein and Androgen Receptor Expression Reveals Independence of Canine Prostate Cancer from Androgen Hormone Stimulation
por: Cavalca, Alexandre Matheus Baesso, et al.
Publicado: (2022)

The androgen-thyroid hormone crosstalk in prostate cancer and the clinical implications
por: Torabinejad, Sepehr, et al.
Publicado: (2023)

Modulation of Androgen Receptor Signaling in Hormonal Therapy-Resistant Prostate Cancer Cell Lines
por: Marques, Rute B., et al.
Publicado: (2011)

Androgens and prostate disease
por: Cooper, Lori A, et al.
Publicado: (2014)

Effects of Androgen Receptor and Androgen on Gene Expression in Prostate Stromal Fibroblasts and Paracrine Signaling to Prostate Cancer Cells
por: Tanner, Matthew J., et al.
Publicado: (2011)

Novel anti-androgen receptor signaling agents: Understanding the mechanisms of resistance
por: Karanika, Styliani, et al.
Publicado: (2014)

Erratum: Skyrmion Creation and Manipulation by Nano-Second Current Pulses
por: Yuan, H. Y., et al.
Publicado: (2016)

Biological and Clinical Significance of Androgens and Androgen Receptor in Prostate Cancer
por: Koochekpour, Shahriar
Publicado: (2014)

Androgen receptor signaling is required for androgen-sensitive human prostate cancer cell proliferation and survival
por: Yang, Qing, et al.
Publicado: (2005)

Androgen receptor axis-targeted agents are not superior to conventional hormonal therapy for treatment of metastatic prostate cancer
por: Wada, Akinori, et al.
Publicado: (2022)

ROLE OF ANDROGEN RECEPTOR-TARGETED AGENTS IN LOCALIZED PROSTATE CANCER
por: Murgić, Jure, et al.
Publicado: (2022)

The Androgen Hormone-Induced Increase in Androgen Receptor Protein Expression Is Caused by the Autoinduction of the Androgen Receptor Translational Activity
por: Siciliano, Tiziana, et al.
Publicado: (2022)

Erratum to: Manipulating Connexin Communication Channels: Use of Peptidomimetics and the Translational Outputs
por: Evans, W. Howard, et al.
Publicado: (2012)

Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours
por: Dart, D Alwyn, et al.
Publicado: (2009)

FRI475 The Impact Of Suppression Of Androgen Signaling On Thyroid Hormone Homeostasis In Prostate Cancer Patients
por: David, Karel, et al.
Publicado: (2023)

Phosphorylation of the Androgen Receptor by PIM1 in Hormone Refractory Prostate Cancer
por: Ha, Susan, et al.
Publicado: (2012)

Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer
por: Chuu, Chih-Pin, et al.
Publicado: (2011)

The Androgen Receptor and VEGF: Mechanisms of Androgen-Regulated Angiogenesis in Prostate Cancer
por: Eisermann, Kurtis, et al.
Publicado: (2017)

Response to Androgens and Androgen Receptor Antagonists in the Presence of Cytokines in Prostate Cancer
por: Culig, Zoran
Publicado: (2021)

Androgen Metabolism and Response in Prostate Cancer Anti-Androgen Therapy Resistance
por: Zhang, Haozhe, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cukrk7kkp0u1cocje41mp3go94